New Times,
New Thinking.

  1. Politics
26 October 2017

The Daily Mail’s witch hunt for university Remainers spectacularly backfires

Trying to root out “anti-Brexit bias” among academics and students has the opposite effect.

By Media Mole

Spare a thought for the Daily Mail. The government is now so outrageously agenda-driven that it’s nicking all of the paper’s limelight.

This week, the Tory whip Chris Heaton-Harris MP got in trouble for writing letters to universities asking for information and names regarding their Brexit teaching.

So the Mail, clearly envious of the attention, and maybe spooked by the Tories’ recent insistence on protecting “free speech” on campus, has decided to make its own McCarthyist move.

Splashing on “Our Remainer Universities”, it has run an article all about how many academics and students are pro-European – ie. highlighting that the UK’s most educated people are against Brexit.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

And as if that doesn’t undermine the Mail’s message enough, it has included a call-out for readers to shop their professors and universities for “anti-Brexit bias”:


It gives an email address and everything. Guess how people are responding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


This mole looks forward to tomorrow, when the Mail will surely publish a round-up of what it has learned from all this intel it asked for… 

Content from our partners
Nutrition must be central to Labour's health mission
How we can continue to innovate in the care of rare diseases
The right deal for all